This site is intended for health professionals only
Saturday 15 December 2018

Kathy Oxtoby

Articles by this author

Thu 6 December
Thu 6 December
Leading academics and health data specialists have formed an alliance to boost science and innovation in the UK
Thu 6 December
Thu 6 December
Delays in taking new cancer drugs through clinical trials and getting them approved for use mean NHS patients are waiting longer to access them, a report by the Institute of Cancer Research (ICR) finds.
Thu 29 November
Thu 29 November
A survey of people working within pharmaceutical industry within and outside the UK found growing negativity about the impact of Brexit on the UK healthcare sector
Thu 22 November
Thu 22 November
AR101 slowly builds up tolerance to peanut allergy, study finds
Wed 17 October
Wed 17 October
Imraldi is approved in Europe for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis and axial spondyloarthritis with radiographic evidence of AS
Thu 5 July
Thu 5 July
Cimzia can be used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, following label extension by European Medicines Agency (EMA)
Wed 4 July
Wed 4 July
A clinical trial to treat female diffuse hair loss has been kick started by US regenerative medicine company Histogen.
Thu 28 June
Thu 28 June
First patient with metastatic breast cancer receives treatment to look at anti-tumour effect and tolerability using new drug response predictor
Thu 28 June
Thu 28 June
First cannabinoid prescription medicine to be approved in the US endorses Epidiolex to treat two rare forms of childhood-onset epilepsy
Wed 27 June
Wed 27 June
Oral Semaglutide demonstrates significant reduction in blood sugar versus placebo in trial
Thu 21 June
Thu 21 June
Targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors
Thu 21 June
Thu 21 June
Global pharmaceutical company to discontinue a late-stage trial assessing the efficacy of an experimental therapy in reducing chronic cluster headaches.
Wed 20 June
Wed 20 June
Idorsia launches PRECISION – Phase 3 study with aprocitentan for resistant hypertension management in adults
Thu 14 June
Thu 14 June
International team of researchers have developed new DNA test to identify men at greatest risk of prostate cancer